首页|MAL2 DNA methylation serves as a biomarker for the diagnosis and prognosis of glioma

MAL2 DNA methylation serves as a biomarker for the diagnosis and prognosis of glioma

扫码查看

Hao Luo、Xing Xiao、Weiliang Hou、Jing Cai、Ming Chen、Qisheng Tang、Yusheng Tong、Zengxin Qi、Kaicheng Li、Liang Chen

展开 >

Department of Neurosurgery,Huashan Hospital,Shanghai Medical College,State Key Laboratory of Medical Neurobiology,MOE Frontiers Center for Brain Science and Institutes of Brain Science,Fudan University,Shanghai 200040,China

National Center for Neurological Disorders,Shanghai 200040,China

Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration,Shanghai 200040,China

Tianqiao and Chrissy Chen Institute Clinical Translational Research Center,Shanghai 200040,China

Shanghai QuietD Biotechnology Co.,Ltd.,Shanghai 201210,China

展开 >

National Natural Science Foundation of ChinaShanghai Municipal Science and Technology Major Project of ChinaZJLab,Science and Technology Commission of Shanghai Municipality,ChinaZJLab,Science and Technology Commission of Shanghai Municipality,ChinaMOE Frontiers Center for Brain ScienceShanghai Shenkang,ChinaShanghai Zhou Liangfu Medical Development Foundation

822721162018SHZDZX0120Z1190010020S11905600SHDC2020CR3073B

2024

基因与疾病(英文)

基因与疾病(英文)

ISSN:
年,卷(期):2024.11(5)